⌘K

Login Start Free

Home/Filings/4/0001349929-14-000018

4//SEC Filing

CANCER GENETICS, INC 4

Accession 0001349929-14-000018

CIK 0001349929operating

View on SEC.gov Company Profile

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 6:51 PM ET

Size

7.0 KB

Accession

0001349929-14-000018

Insider Transaction Report

Form 4

Period: 2014-12-11

CANCER GENETICS, INCCGIX

DirectorChief Executive Officer

Transactions

Award
Common Stock, par value $0.0001 per share
2014-12-11+100,000→ 150,000 total
Award
Stock Option (right to buy)
2014-12-11+250,000→ 250,000 total
Exercise: $6.30Exp: 2024-12-10→ Common Stock (250,000 underlying)

Footnotes (3)

[F1]Restricted Stock
[F2]Restricted Stock vests twenty percent on the date of grant, with subsequent vesting in equal installments over the following forty-eight months.
[F3]Options vest twenty percent on the date of grant, with subsequent vesting in equal installments over the following forty-eight months.

Documents

1 file

4
wf-form4_141868745688455.xmlPrimary
FORM 4

Issuer

CANCER GENETICS, INC

CIK 0001349929

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001349929

Filing Metadata

Form type: 4
Filed: Dec 14, 7:00 PM ET
Accepted: Dec 15, 6:51 PM ET
Size: 7.0 KB

View on SEC.gov